Fullintel Daily Digest

RUTGERS CANCER INSTITUTE OF NEW JERSEY IN THE NEWS NOVEMBER 2021

Delivered by Corporate Media Relations

Service Lines

How to Close the Gap in Breast Cancer Screening, Treatment, Reconstruction, & Mortality Rates

Nov 01 | Online Publication| Debbie Overman | Reach: N/A | Sentiment : Neutral

Plastic Surgery Practice - We also bring back from earlier parts of this series: M. Michele Blackwood, MD, chief of section breast surgery at Rutgers Cancer Institute of New Jersey and professor of surgery at Rutgers Robert Wood Johnson Medical School, and Valerie Gorman, MD, FACS, chief of surgery and medical director of surgical services at the Baylor Scott and White Waxahachie, Texas Surgical Specialists/Texas Breast Center. Read More

Male Breast Cancer Patients Have Oncoplastic Surgical Options, Too

Nov 02 | Online Publication| Debbie Overman | Reach: N/A | Sentiment : Neutral

Plastic Surgery Practice - In addition, when a primary care physician diagnoses a male patient with breast cancer and recommends a breast specialist like Gorman, or M. Michele Blackwood, MD, chief of section breast surgery at Rutgers Cancer Institute of New Jersey, professor of surgery at Rutgers Robert Wood Johnson Medical School, Blackwood says men often assume the choices for plastic and reconstructive surgery are extremely limited, sometimes assuming his only option will be a full mastectomy. But, similar to their female patient counterparts, Blackwood explains that breast cancer treatments for men are not one-size-fits-all. Gorman says breast-conserving surgery can be viable option, depending on the case. The variety of oncoplastic surgical solutions now available for male breast cancer survivors have enabled them to pursue a better quality of life post-procedure. Read More

Marginal Improvement in Survival Among Patients Diagnosed With Metastatic Prostate Cancer in the Second-Line Antiandrogen Therapy Era

Nov 02 | Online Publication | Reach: 201 | Sentiment : Neutral

UroToday - Since 2004, multiple blockbuster drugs have been approved for men with metastatic prostate cancer. Nevertheless, it has been reported that no improvement in survival was observed between 2004 and 2009. Herein, we have analyzed the SEER database to assess the survival outcome of metastatic prostate cancer patients since 2000. The results demonstrated that there was an improvement in both overall and prostate cancer-specific survival for 4 months among men diagnosed with metastatic prostate cancer from 2010 to 2016 when compared to those in the pre-2010 period. Read More

Pembrolizumab Plus Chemoradiation Therapy Elicits Strong Responses in Stage III NSCLC

Nov 02 | Online Publication| Maggie Tibbitt | Reach: 1,312 | Sentiment : Neutral

OncLive - In an interview with OncLive®, Jabbour, professor and vice chair of clinical research and faculty development at The Rutgers Cancer Institute of New Jersey, discusses the validity and clinical implications of using pembrolizumab plus platinum CRT in patients with stage III NSCLC. Read More

Rutgers Cancer Institute, RWJBarnabas Launch State’s First Home Infusion Program

Nov 08 | Online Publication | Reach: 1,348,256 | Sentiment : Positive

New Jersey Patch - “As New Jersey’s only National Cancer Institute - Designated Comprehensive Cancer Center, the patient is always at the center of everything we do. We take tremendous pride in ensuring our patients come first and are committed to providing the highest level of care coupled with excellent patient experience and satisfaction,” notes Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also the senior vice president of oncology services at RWJBarnabas Health. Read More

Also syndicated in:

TAPinto.net, sciencenewsnet.in and New Jersey Business Magazine

Syndicated Reach: TM - 60,675

Sharon Manne Award Supports 4 Psychology Graduate Research Projects

Nov 03 | Organization | Reach: 895,709 | Sentiment : Neutral

Arizona State University - Four Arizona State University Department of Psychology graduate students have been named Sharon Manne Award Scholars, providing funding for personal research projects that address important and timely mental and physical health issues. Sharon Manne is currently a professor in the Department of Medicine at the Robert Wood Johnson School of Medicine and is the associate director of cancer prevention and control at the Rutgers Cancer Institute of New Jersey. Read More

Rutgers Cancer Institute, RWJBarnabas Launch Home Infusion Program

Nov 08 | Online Publication| Gabrielle Saulsbery | Reach: 2,048 | Sentiment : Positive

NJBIZ - The program, run in partnership with Horizon Blue Cross Blue Shield of New Jersey, leverages telemedicine to limit patients' exposure to infectious diseases and to receive one-on-one care from a home health care provider. (Subscription Required) Read More

New Jersey Cancer Center Launches State's 1st Home Infusion Program

Nov 08 | Online Publication| Erica Carbajal | Reach: 109,503 | Sentiment : Positive

Becker's Hospital Review - "Just as the implementation of telemedicine has changed how cancer care is delivered, through this innovative pilot program, we know that cancer treatment can be delivered safely, effectively and less expensively at home," said Andrew Evens, DO, associate director for clinical services at Rutgers Cancer Institute and medical director of the oncology service line at West Orange, N.J.-based RWJBarnabas Health. "The measures we have taken, and will continue to take, at the Rutgers Cancer Institute together with RWJBarnabas Health to provide cancer care during the pandemic have made our healthcare system stronger and will make cancer care better for patients," Dr. Evens said. Read More

HUTCHMED Highlights HMPL-523 Clinical Data to Be Presented at the 2021 ASH Annual Meeting

Nov 08 | Online Publication | Reach: 2,183,342 | Sentiment : Neutral

Yahoo! Finance - HUTCHMED today announces that new analyses and updates on the ongoing studies of HMPL-523 and HMPL-306 will be presented at the upcoming 63rd American Society for Hematology’s Annual Meeting and Exposition, taking place on December 11-14, 2021. The meeting will be held virtually and in person at the Georgia World Congress Center in Atlanta, Georgia U.S. Title: A Phase I, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations. Lead Author: Anu Doraiswamy, MD, Rutgers Cancer Institute of New Jersey. Read More

Also syndicated in:

BioSpace, The Associated Press, Beckley Register-Herald, Kentucky Today, Morningstar.com, Post Register, PM 360, StreetInsider.com, Stockhouse, Benzinga.com and 5 More

Syndicated Reach: TM - 1,326,151

The First Home Infusion Pilot Program for Cancer Patients in NJ Is Underway

Nov 10 | Online Publication| Jen Ursillo | Reach: 7,629 | Sentiment : Positive

New Jersey 101.5 - The Horizon Home Infusion pilot program delivers oncology care to patients in the comfort of their own homes, limiting exposure to hospital settings during the COVID-19 pandemic, said Steven Libutti, director of The Rutgers Cancer Institute of New Jersey and Senior Vice President of Oncology Services at RWJ Barnabas Health. Read More

Also syndicated in:

Beach Radio and 92.7 WOBM

Syndicated Reach: TM - N/A

Supporting Cancer Caregivers: Perspective From an Oncology Nurse

Nov 10 | Online Publication | Reach: 1,348,256 | Sentiment : Positive

New Jersey Patch - Arlene D. Cruz, RN, BSN, OCN, nurse clinician at Rutgers Cancer Institute of New Jersey, helps to examine the issues facing caregivers of patients with cancer and shares how oncology nurses and family caregivers can work together and support each other throughout the cancer journey. Read More

Also syndicated in:

HealthNewsDigest.com

Syndicated Reach: TM - 271

Confronting Disparities in Lung Cancer

Nov 10 | Online Publication | Reach: 1,348,256 | Sentiment : Neutral

New Jersey Patch - Sharon R. Pine, PhD is a resident member of Rutgers Cancer Institute of New Jersey and associate professor of Pharmacology and Medicine at Rutgers Robert Wood Johnson Medical School. Dr. Pine is also a member of the Cancer Health Equity Center of Excellence in partnership with the Rutgers School of Public Health and Rutgers Cancer Institute, and studies racial health disparities in lung cancer. She shares more about the topic. Read More

Pancreatic Cysts, Cancer and Awareness: Answers From an Expert

Nov 10 | Online Publication | Reach: 1,348,256 | Sentiment : Positive

New Jersey Patch - Russell Langan, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at SBMC and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more information on monitoring pancreatic cysts and pancreatic cancer. Read More

Up-Front Surgery, Biologics Do Not Improve Survival in Resectable CRC With Liver Metastases

Nov 11 | Online Publication| Jason Harris | Reach: 1,312 | Sentiment : Neutral

OncLive - “When we’re talking to a patient at the clinic, we can confidently tell…resectable patients that we do cure patients by giving them FOLFOX [leucovorin/5-fluorouracil (5-FU)/oxaliplatin], we just don't have conclusive proof that it changes long-term survival,” said Boland, a member of the Gastrointestinal Oncology team at RWJ Barnabas Health and an assistant professor of medicine at Rutgers Cancer Institute of New Jersey. Read More

Rutgers Cancer Institute and RWJBarnabas Health Establish State’s First Home Infusion Program

Nov 12 | Online Publication | Reach: N/A | Sentiment : Positive

Cancer Letter.com - Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to establish a collaborative pilot program providing home infusion cancer treatments to eligible patients. (Subscription Required) Read More

Training Immune Cells to Be Cancer Killers

Nov 12 | Online Publication| Aparna Nathan | Reach: 19,730 | Sentiment : Neutral

The Scientist - For Christian Hinrichs, an oncologist who leads the cancer immunotherapy division at the Rutgers Cancer Institute, the search for effective treatments is more than just an interesting scientific question—it is a personal one. His own bout with cancer more than a decade earlier made him acutely aware of just how important it is to find therapies that completely eliminate tumors, steering his research toward engineering patients’ own cells to find and kill cancer cells and running clinical trials to bring these treatments into practice. Read More

Are You at Risk for Pancreatic Cysts?

Nov 13 | Online Publication | Reach: 566,189 | Sentiment : Neutral

Physician's Briefings - About 15% of Americans are believed to have pancreatic cysts, which are small fluid-filled pockets that typically cause no symptoms, according to Dr. Russell Langan, a surgical oncologist at Rutgers Cancer Institute of New Jersey and assistant professor at Rutgers Robert Wood Johnson Medical School in New Brunswick, N.J. Read More

Also syndicated in:

U.S. News & World Report, Remon News, Health News Digest, Jaituss, HowYourReadMe.com, Printveela and Drugs.com

Syndicated Reach: TM - 816,189

What You Need to Know About Pancreatic Cancer

Nov 14 | Online Publication | Reach: N/A | Sentiment : Neutral

Knowridge Science Report - Russell Langan, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey, shares more information on monitoring pancreatic cysts and pancreatic cancer. Read More

Cancer Care at Home: Pilot Program Shows Promise

Nov 16 | Online Publication| Tom Bergeron | Reach: 11,656 | Sentiment : Positive

ROI-NJ - Rutgers Cancer Institute of New Jersey and RWJBarnabas Health announced they are partnering with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program that provides home infusion cancer treatments for eligible patients. Dr. Steve Libutti, the director of the Rutgers Cancer Institute and a senior vice president of oncology services at RWJBarnabas Health, said patient care always is at the forefront of treatment. Read More

Medical Researchers Says, Cysts Can Be Cancerous

Nov 18 | Online Publication| Nikki Attkisson | Reach: N/A | Sentiment : Neutral

Powdersville Post - Dr. Russell from Rutgers Cancer Institute in New Jersey states that around 15% of Americans have a pancreatic cyst in their body. However, these are very small and cause no issues to the person. Many times these cysts are identified while doing somebody imaging for other diseases or issues. Once some irregularities are seen the patient is advised to see an expert for this who studies all the factors associated with the cyst on the pancreas. Read More

Assessing Both Sides of the Argument for in-Home Cancer Infusions

Nov 18 | Online Publication| Darlene Dobkowski | Reach: 1,412 | Sentiment : Positive

CURE Magazine - “We are constantly looking for ways to be innovative, and to export knowledge and new paradigms throughout our (health care) network,” said Dr. Andrew M. Evens, associate director for clinical services at Rutgers Cancer Institute of New Jersey and medical director of the oncology service line at RWJBarnabas Health, in an interview with CURE®. “This was an example of our motto that cancer doesn’t travel well. Yes, it emerged out of the (COVID-19) pandemic, looking for ways to be more convenient. At the same time, we want to be safe and effective for patients.” Read More

Exploring How DNA Impacts Cancer Risk and Treatment

Nov 18 | Online Publication | Reach: 271 | Sentiment : Neutral

HealthNewsDigest.com - Germline testing checks an eligible person's DNA for genetic inherited mutations that could potentially increase the risk of developing cancers or other health problems. Researchers from Rutgers Cancer Institute of New Jersey and Dana-Farber Cancer Institute developed and evaluated a computational pipeline that utilizes information commonly provided in academic and commercial tumor sequencing assays to predict the origin of detected DNA alterations with the goal of helping clinicians in identifying germline alterations in patients. Read More

Dr. Ghodoussipour on Ongoing Trials in Non–muscle Invasive Bladder Cancer

Nov 18 | Online Publication| Saum Ghodoussipour | Reach: 1,312 | Sentiment : Neutral

OncLive - Saum Ghodoussipour, MD, urologic oncologist, director, Bladder and Urothelial Cancer Program, Rutgers Cancer Institute of New Jersey, assistant professor of surgery, Rutgers Robert Wood Johnson Medical School, attending, Robert Wood Johnson University Hospital, discusses ongoing trials in non–muscle invasive bladder cancer. Read More

Dr. Toppmeyer on the Utility of De-Escalation Trials in HER2+ Breast Cancer

Nov 18 | Online Publication| Deborah L. Toppmeyer | Reach: 1,312 | Sentiment : Neutral

OncLive - Deborah L. Toppmeyer, MD, Chief Medical Officer and Director of the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute of New Jersey, professor of medicine at Robert Wood Johnson Medical School, attending, Robert Wood Johnson University Hospital, discusses the utility of clinical trials evaluating de-escalated treatment approaches in HER2-positive breast cancer. Read More

Dr. Shah on Trials Examining Cilta-Cel in Relapsed/Refractory Multiple Myeloma

Nov 18 | Online Publication| Mansi R. Shah | Reach: 1,312 | Sentiment : Neutral

OncLive - Mansi R. Shah, MD, hematologist/oncologist, Rutgers Cancer Institute of New Jersey, assistant professor of medicine, Rutgers Robert Wood Johnson Medical School and attending at Robert Wood Johnson University Hospital, discusses ongoing research examining the CAR T-cell therapy ciltacabtagene autoleucel (cilta-cel) for the treatment of patients with relapsed or refractory multiple myeloma. Read More

Dr. Cooper on Leveraging Novel Agents and Combos in Multiple Myeloma

Nov 18 | Online Publication| Dennis Cooper | Reach: 1,312 | Sentiment : Neutral

OncLive - Dennis Cooper, MD, chief of blood and marrow transplantation at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital, sheds light on the novel therapeutic regimens available to patients with multiple myeloma. Read More

Study Provides ‘Critical Information’ for Treating Childhood Cancer Patients With COVID

Nov 18 | Organization| Matt Windsor | Reach: 68,275 | Sentiment : Neutral

UAB Kaleidoscope - In addition to Johnston and Wolfson, both of whom treat patients at Children’s of Alabama, authors of “SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities” are Isaac Martinez, Elizabeth S. Davis, Caroline Caudill, Joshua Richman, M.D., Ph.D., and Smita Bhatia, M.D., of UAB; Julienne Brackett, M.D., of Texas Children’s Hospital; David S. Dickens, M.D., of the University of Iowa; Alissa Kahn, M.D., of Saint Joseph’s University Medical Center; Carla Schwalm, M.D., of Bronson Methodist Hospital; Archana Sharma, D.O., of Rutgers Cancer Institute; Pratik A. Patel, M.D., of Emory University School of Medicine; and Jennifer M. Levine, M.D., of Weill Cornell Medicine. Read More

Managing Holiday Stress With Cancer

Nov 22 | Online Publication | Reach: 1,348,256 | Sentiment : Positive

New Jersey Patch - Gabrielle Alvarez, MSW, LCSW and Samantha Campanella, MSW, L CSW, OSW-C, social workers at Rutgers Cancer Institute of New Jersey, share some practical tips to minimize stress during the holiday season. Read More

Dr. Ganesan on Leveraging Precision Medicine to Improve Cancer Care

Nov 22 | Online Publication| Shridar Ganesan | Reach: 1,312 | Sentiment : Neutral

OncLive - Shridar Ganesan, MD, PhD, Chief, Molecular Oncology and Associate Director for Translational Research at Rutgers Cancer Institute of New Jersey, and attending physician at Robert Wood Johnson University Hospital, discusses improvements in precision medicine and the need to enroll patients with different molecular subtypes into specifically designed clinical trials. Read More

Dr. Hinrichs on Unmet Needs With Cellular Therapy in Metastatic Epithelial Cancer

Nov 23 | Online Publication| Christian S. Hinrichs | Reach: 1,312 | Sentiment : Neutral

OncLive - Christian S. Hinrichs, MD, chief of Cancer Immunotherapy, and co-director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, program co-leader of the Cancer Metabolism and Growth Program at Rutgers Cancer Institute of New Jersey, professor of Medicine at the Rutgers Robert Wood Johnson Medical School, discusses unmet needs with cellular therapies in metastatic epithelial cancer. Read More

Also syndicated in:

GeneTherapyLive

Dr. Malhotra on Challenges With Precision Medicine in Advanced Solid Tumors

Nov 23 | Online Publication| Jyoti Malhotra | Reach: 1,312 | Sentiment : Neutral

OncLive - Jyoti Malhotra, MD, MPH, interim director, Phase I and Investigational Therapeutics Program and medical oncologist, Rutgers Cancer Institute of New Jersey, associate professor of medicine, Rutgers Robert Wood Johnson Medical School, attending physician at Robert Wood Johnson University Hospital, discusses challenges with precision medicine in advanced solid tumors. Read More

Dr. Evens on Key Highlights From the RWJ Annual Clinical Practice and Research Summit

Nov 23 | Online Publication| Andrew M. Evens | Reach: 1,312 | Sentiment : Neutral

OncLive - Andrew M. Evens, DO, MSc, director for clinical services, Rutgers Cancer Institute of New Jersey, system director of Medical Oncology, oncology lead, Combined Medical Group with RWJBarnabas Health, associate vice chancellor, Clinical Innovation and Data Analytics, Rutgers Biomedical and Health Sciences, discusses highlights from the 2021 RWJ Annual Clinical and Practice Research Summit. Read More

12-Year Old Cancer Survivor Designs Devils Blackwood's Mask

Nov 29 | Online Publication| Sean Conklin | Reach: 1,348,256 | Sentiment : Neutral

New Jersey Patch - The Devils also honored Christian Koncewicz, a 9-year-old from Middletown, New Jersey, who was recognized as a special Hero Among Us during Hockey Fights Cancer Night. He was diagnosed with Leukemia this past April and is currently undergoing treatment at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital. Read More

New Cancer Therapy From Yibin Kang’s Lab Holds Potential to Switch off Major Cancer Types Without Side Effects

Nov 29 | Organization | Reach: 64,945 | Sentiment : Neutral

EurekAlert! - This research was also supported by the Preclinical Imaging and Flow Cytometry Shared Resources of the Rutgers Cancer Institute of New Jersey (P30CA072720). Read More

Also syndicated in:

Mirage News and Princeton University

Syndicated Reach: TM - 9,991

Cancer Prevention and Control

Nov 30 | Online Publication | Reach: 1,348,256 | Sentiment : Neutral

New Jersey Patch - In a recent paper, investigators from Rutgers University including Rutgers Cancer Institute of New Jersey, Rutgers School of Public Health and Rutgers Robert Wood Johnson Medical School recently addressed the progress of behavioral and preventative medicine and the mission and vision of cancer prevention and control research in the future. Read More

Also syndicated in:

Newsfounded

Syndicated Reach: TM - N/A

Hochster Shares Best Practices on Molecular Markers and Sequencing in Gastric Cancer

Nov 29 | Online Publication| Maggie Tibbitt | Reach: 1,312 | Sentiment : Neutral

OncLive - In an interview with OncLive, Hochster, who is an associate director of clinical research and director of gastrointestinal oncology at Rutgers Cancer Institute of New Jersey and director of oncology research for RWJBarnabas Health, discussed molecular markers for patients with gastric cancer, using gene expression profiles as biomarkers, and choosing between anti–PD-1 and anti–CTLA-4 agents. Read More

Moving the Mark

Nov 30 | Online Publication| Anne DiNardo | Reach: 908 | Sentiment : Neutral

Healthcare Design - Here’s a roundup of new and recently renovated cancer care facilities that are delivering thoughtful and holistic built environment solutions to respond to modern care needs. Rutgers Cancer Institute of New Jersey Jack and Sheryl Morris Cancer Center, New Brunswick, N.J. Read More

Recommended by Fullintel Analysts

You are currently subscribed as info@fullintel.com. For further assistance, please contact Customer Service at support@fullintel.com

Unsubscribe | Privacy Policy